Transurethral resection of the prostate (TURP) is a surgical procedure to remove excess part of the prostate gland which obstructs normal urine flow. The prostate gland is a vital part of the male reproductive system which secretes fluid that nourishes and protects sperms. This obstructive condition of prostate is also referred as benign prostatic hyperplasia (BPH). Initial signs and symptoms of BPH are often vague, variable, and nonspecific, making its diagnosis challenging. During TURP procedure, prostate gland is investigated through the cystoscope (surgical instrument) and a small surgical tool is inserted through the cystoscope to remove the enlarged prostate. Sometimes, the fluid that is used to flush bladder during transurethral resection enters into bloodstream and causes severe problems such as hypothermia, bradychardia and hypoxia. This condition is known as TUR syndrome and is temporary in nature.
Get Free Sample Report Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6856
For more than 60 year, TURP has been the gold standard for treating lower urinary tract obstructions caused by benign prostatic hyperplasia (BPH) and benign prostatic obstruction (BPO). Current technological advancements such as continuous-flow instruments, bipolar TURP and video-TURP have substantially decreased the mortality and morbidity due to urino-genital infections. Globally increasing elderly population has been identified as one of the major factors contributing to the growing demand for transurethral resection procedures. As per the U.S National Library of Medicine, 60% of men over the age of sixty years and 80% of men over the age of 80 years have been diagnosed as BPH patients. Visual, hands-on access to the prostate, immediate removal of excess tissue and ability to combine with other procedures are some of the advantages of TURP over other available treatment options for lower urinary tract infections.
Some major minimally invasive treatment options for BPH include lasers, microwave, radio waves, photoselective laser vaporization of the prostate (PVP) and ultrasound. These treatment options are expected to serve the market for TURP as growth restraints during the forecast period from 2014 to 2019. Moreover, medications, another possible treatment option such as alpha 1-blockers, antibiotics, finasteride and dutasteride to decrease the size of the prostate are also restraining the current TURP market.
Resectoscopes, catheters and resectoscopes electrodes (monopolar electrodes bipolar electrodes, grooved roller turp electrodes and straight cutting loop turp electrodes) are some major devices that are widely used during TURP procedures.Based on geography, the TURP market has been analyzed as North America, Asia-Pacific,Europe, and the Rest of the World (RoW). North America and Europe held the largest shares in terms of market revenue of the global TURP market in 2013. The primary reasons for North America and Europe holding the leading positions in the global TURP market are high prevalence of lower urinary tract diseases such as BPH and BPO, and well established healthcare infrastructure in both the regions. According to the American Urological Association, 15 million men in the United States are symptomatic to BPH and in the approximately 150,000 people have TURPs performed each year. However, Asia-Pacific is expected to witness highest growth rate during the forecast period from 2014 to 2020.
A number of factors such as increasing prevalence of urinary tract infections, aging population, increasing focus on research and development would be fuelling the growth of TURP market in Asia-Pacific in coming years. According to the Department of Economic and Social Affairs, United Nations, 23 million individuals aged 80 years or over were living in China in 2013. The Department of Economic and Social Affairs further states that nearly 10 million and 9 million individuals aged 80 years or over were living in India and Japan, respectively in 2013.Some of the major players in TURP market include Olympus Corporation, Richard Wolf, Degania Silicone Ltd, Limbs & Things Ltd and KARL STORZ GmbH & Co. KG.